Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 2
2012 3
2013 4
2014 4
2015 2
2016 4
2017 2
2018 2
2019 5
2020 1
2021 6
2022 7
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Ustekinumab: moving the target from psoriasis to Crohn's disease.
Settesoldi A, Coppola M, Rogai F, Annese V. Settesoldi A, et al. Among authors: rogai f. Expert Rev Gastroenterol Hepatol. 2014 Jan;8(1):5-13. doi: 10.1586/17474124.2014.850414. Epub 2013 Nov 25. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24410468 Review.
Incidence, risk and protective factors of symptoms after colonoscopy.
Collatuzzo G, Boffetta P, Radaelli F, Cadoni S, Hassan C, Frazzoni L, Anderloni A, Laterza L, La Marca M, Rogai F, Binda C, Montale A, Soriani P, Fabbri C, Sacco M, Gallittu P, Mura D, Trovato C, Vitale G, Mussetto A, Musso A, Conti CB, Manno M, Repici A, Zagari RM, Farioli A, Fuccio L. Collatuzzo G, et al. Among authors: rogai f. Dig Liver Dis. 2022 Dec;54(12):1698-1705. doi: 10.1016/j.dld.2022.08.025. Epub 2022 Sep 23. Dig Liver Dis. 2022. PMID: 36154988
PPARγ in Inflammatory Bowel Disease.
Annese V, Rogai F, Settesoldi A, Bagnoli S. Annese V, et al. Among authors: rogai f. PPAR Res. 2012;2012:620839. doi: 10.1155/2012/620839. Epub 2012 Sep 10. PPAR Res. 2012. PMID: 22997506 Free PMC article.
Determinants of symptom burden related to bowel preparation for colonoscopy.
Collatuzzo G, Fuccio L, Frazzoni L, Radaelli F, Hassan C, Fabbri C, Cadoni S, Laterza L, Anderloni A, Binda C, La Marca M, Montale A, Soriani P, Sacco M, Gallittu P, Mura D, Manno M, Mussetto A, Rogai F, Trovato C, Vitale G, Musso A, Conti CB, Repici A, Farioli A, Zagari RM, Boffetta P. Collatuzzo G, et al. Among authors: rogai f. Dig Liver Dis. 2022 Nov;54(11):1554-1560. doi: 10.1016/j.dld.2022.06.005. Epub 2022 Jun 28. Dig Liver Dis. 2022. PMID: 35778229
35 results